the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Malaysia’s role limited to mediation in Thailand-Cambodia border dispute

Prime Minister Anwar Ibrahim clarifies Malaysia’s position as a mediator only, with resolution dependent on Thailand and Cambodia’s direct agreement.

PUTRAJAYA: Prime Minister Datuk Seri Anwar Ibrahim has stated that Malaysia’s position is solely to help mediate and ensure a cessation of hostilities in the Thailand-Cambodia border issue.

He emphasised that the final decision rests entirely with the two neighbouring countries. “We (Malaysia) don’t decide,” Anwar said during a special press conference.

He described recent criticism of Malaysia’s role as based on “pure ignorance and prejudice.”

Anwar outlined that all diplomatic efforts, including the Kuala Lumpur Peace Accords and meetings coordinated by Malaysia’s foreign minister, were conducted with the full agreement of both parties.

He noted his consistently “very reserved” and “cautious” approach in discussions with Thai Prime Minister Anutin Charnvirakul and Cambodian Prime Minister Hun Manet.

Malaysia’s Chief of Armed Forces and Foreign Minister have also maintained contact with their counterparts in both nations.

Anwar welcomed the recent agreement by Cambodia and Thailand to consolidate their ceasefire through direct talks hosted in China.

He said the swift move to structured discussions reflects a determination to prevent relapse and stabilise the situation durably.

“I am grateful for China’s role in hosting these discussions and in providing a setting in which both sides were able to focus on practical steps to reduce risk and rebuild confidence,” he added.

The Prime Minister also recognised the vital role of United States President Donald J. Trump in helping broker the Kuala Lumpur Peace Accords.

“That involvement contributed to creating the political space in which the parties were able to step back from confrontation and commit to restraint,” Anwar said.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings